Chemotherapy/Pembrolizumab Improves pCR in Key ER+ Breast Cancer Subgroups.

Subjects

Subjects :

THERAPEUTIC use of monoclonal antibodies
POLYMERASE chain reaction
BREAST tumors
CANCER chemotherapy
ESTROGEN receptors
GENE expression
MONOCLONAL antibodies
COMBINED modality therapy
OVERALL survival

Details

Language :

English

ISSN :

15398226

Volume :

13

Issue :

2

Database :

Complementary Index

Journal :

Targeted Therapies in Oncology

Publication Type :

Periodical

Accession number :

175884344